CDC25A and lung carcinoma: Subsequently, we found that knockdown of YBX1 by siRNA significantly decreased CDC25a activity and inhibited growth in vitro and in vivo, which indicated the key role of YBX1/CDC25a axis involved in lung cancer development and progression.